Companies: 10,795·Total market cap: $144.5T

enGene Holdings Inc.

enGene Holdings Inc.

ENGNNASDAQHealthcare● Active

$1.64

$-0.08(-4.65%)

Market Cap$83959762

P/E Ratio—

52W High$12.25

52W Low$1.4

Avg Volume1.6M

Open$1.71

Beta-0.29

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

enGene Holdings Inc.（ENGN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ENGN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.24Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield3.50%Dividend history

Shares Outstanding51.1MShares outstanding history

Next EarningsJun 11, 2026Est.Earnings history

探索 enGene Holdings Inc. 数据

分析师预测$7 · Hold

盈利EPS $-2.29-56.85%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$117.3M▼ 112.73% YoY

202320242025

FY 2025EPS$-2.29▼ 56.85% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$122.4MEPS: $-1.24View income statement →

分析师评级与目标价

Hold9 位分析师

Strong Buy

0

Buy

4

Hold

5

Sell

0

Strong Sell

0

12-Month Price Target

$2.00Low

$1.64Current

$7.00Avg Target上涨空间 326.83%

$28.00High

合计: 9 · 买入占比: 44.4%

根据过去 3 个月内 9 位华尔街分析师，ENGN 共识评级为 Hold，12 个月平均目标价 $7.00 （较现价 $1.64 上涨空间 326.83%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

enGene Holdings Inc.

$1.64-4.65%$84.0M #2

$2.25-6.25%$229.0M #3

Altimmune, Inc.

$2.71-7.19%$239.2M #4

Amarin Corporation plc

$13.93+0.94%$288.1M #5

$5.29-2.94%$632.7M #6

Alto Neuroscience, Inc.

$18.26-8.84%$640.8M

股票表现

1D-4.65%

1W-5.20%

1M+9.33%

3M-81.11%

YTD-81.84%

1Y-51.04%

5Y-91.80%

关于 enGene Holdings Inc.

CEORonald H. W. Cooper

IPO DateFeb 1, 2022

Employees56

CountryCA

Websiteengene.com

enGene Holdings Inc. through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues an…

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

enGene Holdings Inc.（ENGN）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 1, 2022 在 NASDAQ 上市。截至最近交易日，ENGN 股价为 $1.64，市值约为 $84.0M。过去12个月累计回报 -51.04%，年初至今回报 -81.84%。

根据 9 位华尔街分析师，enGene Holdings Inc. 股票共识评级为Hold，12个月平均目标价为 $7.00。2025 财年 enGene Holdings Inc. 营收 —，净利润 -$117.3M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，enGene Holdings Inc.（ENGN）股价为 $1.64，在 NASDAQ 上市，52周区间为 $1.40 – $12.25。

ENGN 最新股价ENGN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议